South African Analgesics Industry Report Report
Post# of 8734
(Total Views: 228)
Posted On: 09/01/2025 1:39:41 PM
South African Analgesics Industry Report
Report Highlights
Global Market Size: The global Analgesics market is projected to reach approximately US$35.3 billion in 2025 and is expected to grow at a CAGR of 6.4%, reaching approximately US$48.1 billion in 2029.
South African Analgesics Market Value: Forecast to grow at a compound annual growth rate of 9.0% until 2029.
Locally and globally, there is growing demand for alternative pain-relief products that utilise advanced technology, such as artificial intelligence, reshaping how pain is managed and treated. This trend is being driven by the need for safer, more precise, non-addictive, and non-invasive painkiller solutions, amid rising concerns about the side effects of traditional pharmaceutical Analgesics.
Globally, innovations like Nevro’s HFX AdaptiveAI and Medtronic’s Inceptiv™ spinal cord stimulators offer personalised pain relief using AI and closed-loop systems. Other technologies, such as New4Med’s nerve ablation therapy, provide long-term pain management without drugs or surgery.
In South Africa, tech-based Analgesics are gaining momentum. Devices like Nerivio and ActiPatch offer wearable, drug-free solutions for migraines and chronic pain, while interest in red light therapy is growing within the broader wellness and alternative care space.
https://insightsurvey.co.za/industry-report-s...ry-report/
Also noted, the Adcock Ingram ActiPatch website is down for maintenance.
https://actipatch.co.za/
Report Highlights
Global Market Size: The global Analgesics market is projected to reach approximately US$35.3 billion in 2025 and is expected to grow at a CAGR of 6.4%, reaching approximately US$48.1 billion in 2029.
South African Analgesics Market Value: Forecast to grow at a compound annual growth rate of 9.0% until 2029.
Locally and globally, there is growing demand for alternative pain-relief products that utilise advanced technology, such as artificial intelligence, reshaping how pain is managed and treated. This trend is being driven by the need for safer, more precise, non-addictive, and non-invasive painkiller solutions, amid rising concerns about the side effects of traditional pharmaceutical Analgesics.
Globally, innovations like Nevro’s HFX AdaptiveAI and Medtronic’s Inceptiv™ spinal cord stimulators offer personalised pain relief using AI and closed-loop systems. Other technologies, such as New4Med’s nerve ablation therapy, provide long-term pain management without drugs or surgery.
In South Africa, tech-based Analgesics are gaining momentum. Devices like Nerivio and ActiPatch offer wearable, drug-free solutions for migraines and chronic pain, while interest in red light therapy is growing within the broader wellness and alternative care space.
https://insightsurvey.co.za/industry-report-s...ry-report/
Also noted, the Adcock Ingram ActiPatch website is down for maintenance.
https://actipatch.co.za/
(1)
(0)